Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1977

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

Figure-1 (Image 01)
This seems to be a table with columns for mean plasma concentrations of dextro and levoamphetamine at different intervals, expressed in ngint. The table also lists possible variations or alternative names for both types of amphetamines. However, there is some missing or garbled text which makes it difficult to provide a more detailed description.*
FDA Label Image

Label (Lbl636291977)

Label (Lbl636291977)
This text is the label of a medication called NILD, an extended-release capsule for attention deficit hyperactivity disorder (ADHD). It contains a combination of amphetamine and dextroamphetamine salts of various strengths. It is advised to store the medication at room temperature in a tightly sealed container and out of reach of children. The NDC number and dosage information is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.